Introduction
The Kanae Foundation for the Promotion of Medical Science was established in October 1970 for the purpose of supporting original research by young investigators engaged in the life sciences. The Kanae Foundation also promotes the broader goal of contributing to the advancement of medicine and pharmacy as well as national health care. Since its inception, the Kanae Foundation has provided grants for research and foreign study to many young investigators across a broad range of medical and pharmaceutical studies. The Kanae Foundation was recognized and granted as Public Benefit Corporation by the Public Interest Corporation Commission in April 2011.
The name of the Kanae Foundation was inspired by a traditional three-legged bronze vessel, now considered a treasure, that was passed from one Chinese ruler to his successor. Just as a kanae requires the support of three legs, so does the health of the nation rely on cooperation among three partners: pharmaceutical manufacturers, Health Authority, and physicians.
As part of its commitment to promoting health care in Japan, Sanofi KK provides the financial support for the Kanae Foundation's activities. This extends from the long history of the Sanofi legacy companies, beginning with Funai Pharmaceutical Co, Ltd. which in 1970 established the Foundation as The Kanae Foundation of Research for New Medicine. The foundation was renamed The Kanae Foundation for the Promotion of Medical Science in 1997.
The founding Chairman of the Board of Directors was Professor Toshio Kurokawa, who was President of Tohoku University. Through the years a number of distinguished medical leaders have volunteered their time to support the mission of the foundation. A Board of Directors and a Board of Councilors, leaders in the field of medical and pharmaceutical research, serve as an operating committee to carry out the direction.
From the innovative discovery to the clinical application, the Kanae Foundation has provided grants for research and foreign study by promoting original research of the life science field. Applicants must be 40 years of age or younger to be considered for research grants; the age is 35 years or younger for consideration of foreign study grants.
A call for grant applications is issued each June, and the application period closes at the end of July. The applications are reviewed by the Selection Committee. The recommendations of the committee are then presented to the Board of Directors for final endorsement. Recipients are announced at the end of October.
The name of the Kanae Foundation was inspired by a traditional three-legged bronze vessel, now considered a treasure, that was passed from one Chinese ruler to his successor. Just as a kanae requires the support of three legs, so does the health of the nation rely on cooperation among three partners: pharmaceutical manufacturers, Health Authority, and physicians.
As part of its commitment to promoting health care in Japan, Sanofi KK provides the financial support for the Kanae Foundation's activities. This extends from the long history of the Sanofi legacy companies, beginning with Funai Pharmaceutical Co, Ltd. which in 1970 established the Foundation as The Kanae Foundation of Research for New Medicine. The foundation was renamed The Kanae Foundation for the Promotion of Medical Science in 1997.
The founding Chairman of the Board of Directors was Professor Toshio Kurokawa, who was President of Tohoku University. Through the years a number of distinguished medical leaders have volunteered their time to support the mission of the foundation. A Board of Directors and a Board of Councilors, leaders in the field of medical and pharmaceutical research, serve as an operating committee to carry out the direction.
From the innovative discovery to the clinical application, the Kanae Foundation has provided grants for research and foreign study by promoting original research of the life science field. Applicants must be 40 years of age or younger to be considered for research grants; the age is 35 years or younger for consideration of foreign study grants.
A call for grant applications is issued each June, and the application period closes at the end of July. The applications are reviewed by the Selection Committee. The recommendations of the committee are then presented to the Board of Directors for final endorsement. Recipients are announced at the end of October.